Selfotel
Alternative Names: CGS 19755; SefotelLatest Information Update: 21 Mar 2000
At a glance
- Originator Novartis
- Class Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Brain injuries; Cerebrovascular disorders; Cognition disorders; Stroke